vs
Mativ Holdings, Inc.（MATV）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
Mativ Holdings, Inc.的季度营收约是MADRIGAL PHARMACEUTICALS, INC.的1.4倍（$463.1M vs $321.1M），Mativ Holdings, Inc.净利率更高（21.8% vs -18.2%，领先40.0%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 1.0%），Mativ Holdings, Inc.自由现金流更多（$8.0M vs $-133.8M）
Mativ Holdings是一家全球特种材料制造商，主要生产高性能先进聚合物、无纺布、过滤解决方案及功能性涂层材料，服务医疗、工业、消费品、航空航天、能源等领域，业务遍及北美、欧洲及亚太地区。
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
MATV vs MDGL — 直观对比
营收规模更大
MATV
是对方的1.4倍
$321.1M
营收增速更快
MDGL
高出209.8%
1.0%
净利率更高
MATV
高出40.0%
-18.2%
自由现金流更多
MATV
多$141.8M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $463.1M | $321.1M |
| 净利润 | $100.8M | $-58.6M |
| 毛利率 | 18.8% | — |
| 营业利润率 | 2.2% | -18.6% |
| 净利率 | 21.8% | -18.2% |
| 营收同比 | 1.0% | 210.8% |
| 净利润同比 | 6620.0% | 1.4% |
| 每股收益（稀释后） | $1.87 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MATVMDGL
| Q4 25 | $463.1M | $321.1M | ||
| Q3 25 | $513.7M | $287.3M | ||
| Q2 25 | $525.4M | $212.8M | ||
| Q1 25 | $484.8M | $137.3M | ||
| Q4 24 | $458.6M | $103.3M | ||
| Q3 24 | $498.5M | $62.2M | ||
| Q2 24 | $523.8M | — | ||
| Q1 24 | $500.2M | $0 |
净利润MATVMDGL
| Q4 25 | $100.8M | $-58.6M | ||
| Q3 25 | $-3.2M | $-114.2M | ||
| Q2 25 | $-9.5M | $-42.3M | ||
| Q1 25 | $-425.5M | $-73.2M | ||
| Q4 24 | $1.5M | $-59.4M | ||
| Q3 24 | $-20.8M | $-107.0M | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $-28.0M | $-147.5M |
毛利率MATVMDGL
| Q4 25 | 18.8% | — | ||
| Q3 25 | 19.3% | — | ||
| Q2 25 | 19.7% | — | ||
| Q1 25 | 15.0% | 96.7% | ||
| Q4 24 | 16.9% | — | ||
| Q3 24 | 18.8% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 16.8% | — |
营业利润率MATVMDGL
| Q4 25 | 2.2% | -18.6% | ||
| Q3 25 | 3.1% | -39.7% | ||
| Q2 25 | 3.8% | -22.2% | ||
| Q1 25 | -88.8% | -57.8% | ||
| Q4 24 | 0.6% | -64.8% | ||
| Q3 24 | 1.4% | -187.1% | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | -2.8% | — |
净利率MATVMDGL
| Q4 25 | 21.8% | -18.2% | ||
| Q3 25 | -0.6% | -39.8% | ||
| Q2 25 | -1.8% | -19.9% | ||
| Q1 25 | -87.8% | -53.4% | ||
| Q4 24 | 0.3% | -57.5% | ||
| Q3 24 | -4.2% | -172.0% | ||
| Q2 24 | -0.3% | — | ||
| Q1 24 | -5.6% | — |
每股收益（稀释后）MATVMDGL
| Q4 25 | $1.87 | $-2.55 | ||
| Q3 25 | $-0.06 | $-5.08 | ||
| Q2 25 | $-0.18 | $-1.90 | ||
| Q1 25 | $-7.82 | $-3.32 | ||
| Q4 24 | $0.03 | $-2.50 | ||
| Q3 24 | $-0.38 | $-4.92 | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $-0.52 | $-7.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.2M | $198.7M |
| 总债务越低越好 | $1.0B | $339.9M |
| 股东权益账面价值 | $498.7M | $602.7M |
| 总资产 | $2.1B | $1.3B |
| 负债/权益比越低杠杆越低 | 2.07× | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资MATVMDGL
| Q4 25 | $84.2M | $198.7M | ||
| Q3 25 | $97.1M | $295.7M | ||
| Q2 25 | $95.6M | $186.2M | ||
| Q1 25 | $84.0M | $183.6M | ||
| Q4 24 | $94.3M | $100.0M | ||
| Q3 24 | $162.2M | $232.7M | ||
| Q2 24 | $133.4M | — | ||
| Q1 24 | $128.9M | $622.5M |
总债务MATVMDGL
| Q4 25 | $1.0B | $339.9M | ||
| Q3 25 | $1.0B | $339.8M | ||
| Q2 25 | $1.1B | $118.4M | ||
| Q1 25 | $1.1B | $118.0M | ||
| Q4 24 | $1.1B | $117.6M | ||
| Q3 24 | $1.2B | $117.1M | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | $116.1M |
股东权益MATVMDGL
| Q4 25 | $498.7M | $602.7M | ||
| Q3 25 | $397.4M | $625.7M | ||
| Q2 25 | $416.6M | $696.0M | ||
| Q1 25 | $428.2M | $710.6M | ||
| Q4 24 | $858.5M | $754.4M | ||
| Q3 24 | $882.3M | $777.2M | ||
| Q2 24 | $898.0M | — | ||
| Q1 24 | $906.9M | $850.8M |
总资产MATVMDGL
| Q4 25 | $2.1B | $1.3B | ||
| Q3 25 | $2.0B | $1.4B | ||
| Q2 25 | $2.1B | $1.0B | ||
| Q1 25 | $2.1B | $996.6M | ||
| Q4 24 | $2.4B | $1.0B | ||
| Q3 24 | $2.6B | $1.1B | ||
| Q2 24 | $2.6B | — | ||
| Q1 24 | $2.7B | $1.1B |
负债/权益比MATVMDGL
| Q4 25 | 2.07× | 0.56× | ||
| Q3 25 | 2.63× | 0.54× | ||
| Q2 25 | 2.66× | 0.17× | ||
| Q1 25 | 2.67× | 0.17× | ||
| Q4 24 | 1.30× | 0.16× | ||
| Q3 24 | 1.32× | 0.15× | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | 1.30× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.3M | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | $8.0M | $-133.8M |
| 自由现金流率自由现金流/营收 | 1.7% | -41.7% |
| 资本支出强度资本支出/营收 | 2.4% | 0.1% |
| 现金转化率经营现金流/净利润 | 0.19× | — |
| 过去12个月自由现金流最近4个季度 | $93.8M | — |
8季度趋势，按日历期对齐
经营现金流MATVMDGL
| Q4 25 | $19.3M | $-133.5M | ||
| Q3 25 | $72.8M | $79.8M | ||
| Q2 25 | $57.6M | $-47.1M | ||
| Q1 25 | $-15.9M | $-88.9M | ||
| Q4 24 | $24.1M | $-104.5M | ||
| Q3 24 | $37.6M | $-67.0M | ||
| Q2 24 | $46.1M | — | ||
| Q1 24 | $-13.0M | $-149.2M |
自由现金流MATVMDGL
| Q4 25 | $8.0M | $-133.8M | ||
| Q3 25 | $66.7M | $79.0M | ||
| Q2 25 | $48.9M | — | ||
| Q1 25 | $-29.8M | — | ||
| Q4 24 | $2.0M | $-104.7M | ||
| Q3 24 | $25.5M | $-67.8M | ||
| Q2 24 | $37.4M | — | ||
| Q1 24 | $-25.1M | $-149.5M |
自由现金流率MATVMDGL
| Q4 25 | 1.7% | -41.7% | ||
| Q3 25 | 13.0% | 27.5% | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | -6.1% | — | ||
| Q4 24 | 0.4% | -101.3% | ||
| Q3 24 | 5.1% | -109.0% | ||
| Q2 24 | 7.1% | — | ||
| Q1 24 | -5.0% | — |
资本支出强度MATVMDGL
| Q4 25 | 2.4% | 0.1% | ||
| Q3 25 | 1.2% | 0.3% | ||
| Q2 25 | 1.7% | 0.0% | ||
| Q1 25 | 2.9% | 0.0% | ||
| Q4 24 | 4.8% | 0.2% | ||
| Q3 24 | 2.4% | 1.3% | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 2.4% | — |
现金转化率MATVMDGL
| Q4 25 | 0.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 16.07× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MATV
| Other | $208.7M | 45% |
| SAS Segment | $157.4M | 34% |
| FAM Segment | $97.0M | 21% |
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
